​

Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?

OverviewFinancialsChart

Oruka Therapeutics Ownership Summary

Oruka Therapeutics is owned by 77.34% institutional investors, and 22.66% retail investors.

ORKA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOruka Therapeutics77.34%-22.66%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20246657.14%31,038,32126.38%770.29%4916.67%8-
Sep 30, 202442-24,559,501-163-42---

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--

ORKA Ownership FAQ

Who Owns Oruka Therapeutics?

Oruka Therapeutics shareholders are primarily institutional investors at 77.34%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Oruka Therapeutics's industry, Biotech Stocks , is 68.48%, which Oruka Therapeutics exceeds.

Does Blackrock own Oruka Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oruka Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools